Universe Pharmaceuticals (UPC) Receivables - Other: 2021-2024
- Universe Pharmaceuticals' Receivables - Other rose 195.10% to $5.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.7 million, marking a year-over-year increase of 195.10%. This contributed to the annual value of $5.7 million for FY2024, which is 195.10% up from last year.
- Universe Pharmaceuticals' Receivables - Other amounted to $5.7 million in Q3 2024, which was up 195.10% from $1.9 million recorded in Q3 2023.
- Over the past 5 years, Universe Pharmaceuticals' Receivables - Other peaked at $5.7 million during Q3 2024, and registered a low of $236,982 during Q3 2021.
- For the 3-year period, Universe Pharmaceuticals' Receivables - Other averaged around $2.6 million, with its median value being $1.9 million (2023).
- Data for Universe Pharmaceuticals' Receivables - Other shows a peak YoY spiked of 195.10% (in 2024) over the last 5 years.
- Over the past 4 years, Universe Pharmaceuticals' Receivables - Other (Quarterly) stood at $236,982 in 2021, then reached $356,290 in 2022, then reached $1.9 million in 2023, then spiked by 195.10% to $5.7 million in 2024.
- Its Receivables - Other stands at $5.7 million for Q3 2024, versus $1.9 million for Q3 2023 and $356,290 for Q1 2022.
